PUBLISHER: The Business Research Company | PRODUCT CODE: 1945209
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945209
A fluorescent in situ hybridization (FISH) probe is a short sequence of single-stranded DNA or RNA labeled with a fluorescent dye, designed to bind (hybridize) to a specific complementary DNA or RNA sequence within a cell or tissue sample. This method enables visualization and localization of specific genetic material in chromosomes, nuclei, or tissue sections using a fluorescence microscope.
The primary types of FISH probes include deoxyribonucleic acid (DNA) probes, ribonucleic acid (RNA) probes, and multiplex probes. DNA probes are molecules that carry the genetic instructions essential for the growth, development, functioning, and reproduction of all known living organisms and many viruses. These probes target genes and chromosomes and utilize various technologies, including single-color FISH, multiplex FISH, quantitative FISH, and others. FISH probes are applied in clinical diagnostics, research, agricultural biotechnology, pharmaceutical research, and genetic studies, serving multiple end users such as hospitals and clinics, research laboratories, pharmaceutical companies, and biotechnology firms.
Tariffs are impacting the FISH probe market by increasing costs for imported fluorescent dyes, probe synthesis equipment, and advanced imaging instruments. Segments such as multiplex probes and high-throughput screening probes are most impacted, with Asia-Pacific regions including China and India facing notable import duties. While tariffs have increased production costs and slowed procurement in some regions, they have also encouraged local manufacturing, innovation in probe synthesis technologies, and development of cost-efficient alternatives.
The fluorescent in situ hybridization probe market research report is one of a series of new reports from The Business Research Company that provides fluorescent in situ hybridization probe market statistics, including fluorescent in situ hybridization probe industry global market size, regional shares, competitors with a fluorescent in situ hybridization probe market share, detailed fluorescent in situ hybridization probe market segments, market trends and opportunities, and any further data you may need to thrive in the fluorescent in situ hybridization probe industry. This fluorescent in situ hybridization probe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The fluorescent in situ hybridization probe market size has grown strongly in recent years. It will grow from $1.68 billion in 2025 to $1.8 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to limited availability of fluorescent probes, reliance on conventional single-color FISH, growing awareness of genetic diagnostics, increasing research funding in molecular biology, adoption of fluorescence microscopy.
The fluorescent in situ hybridization probe market size is expected to see strong growth in the next few years. It will grow to $2.39 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to development of multiplex and combinatorial barcoded probes, rising applications in personalized medicine, expansion of pharmaceutical and biotechnology research, increasing regulatory compliance and standardization, integration with ai-driven image analysis and data analytics. Major trends in the forecast period include rising adoption of fish probes in clinical diagnostics, expansion of multiplex and high-throughput screening techniques, increasing use in genetic and agricultural research, integration with advanced imaging and analysis tools, focus on custom probe development for personalized medicine.
The growing adoption of personalized medicine is expected to drive the growth of the fluorescent in situ hybridization probe market in the coming years. Personalized medicine is a healthcare approach that utilizes information about an individual's genetic makeup and lifestyle environment to customize medical treatments and care to their specific requirements. The increasing uptake of personalized medicine is driven by patient preference for health technologies that deliver real-time monitoring and treatment strategies tailored to unique biological characteristics. Fluorescent in situ hybridization (FISH) probes support personalized medicine by enabling the accurate identification of genetic abnormalities at the chromosomal level, thereby informing individualized therapeutic decisions based on a patient's distinct genetic profile. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the U.S. Food and Drug Administration approved 16 new personalized therapies for patients with rare diseases in 2023, compared with six approvals in 2022. Therefore, the increasing adoption of personalized medicine is fueling the growth of the fluorescent in situ hybridization probe market.
Major companies operating in the fluorescent in situ hybridization probe market are increasingly emphasizing strategic collaborations to gain access to new markets, technologies, and specialized expertise that may be challenging or costly to develop independently. Strategic collaboration refers to a structured partnership between two or more organizations that combine their complementary strengths and resources to achieve shared long-term objectives and mutual benefits. For instance, in April 2025, Empire Genomics, a US-based molecular diagnostics company, partnered with BioDot, a US-based provider of precision dispensing automation, to introduce the BDot Probe Line. The BDot Probe Line delivers a differentiated offering by providing FISH probes that are pre-optimized for automated platforms, addressing a critical challenge faced by clinical cytogenetics and molecular pathology laboratories. These probes are engineered for direct use without manual modification, ensuring seamless compatibility with the BioDot CellWriter S system. This advancement minimizes technician intervention, streamlines laboratory workflows, and reduces turnaround times. The initial BDot Probe Panels support FISH analysis across a broad range of hematologic malignancies, including multiple myeloma (MM), myelodysplastic syndromes (MDS), chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and other common blood-related conditions.
In April 2025, BioDot Inc., a US-based technology company, also collaborated with Empire Genomics LLC to further enhance automation within cytogenetic and molecular diagnostic workflows. Through this partnership, BioDot and Empire Genomics seek to optimize laboratory operations by integrating the CellWriter S automated platform with pre-optimized hematology probe panels, delivering improved precision, reduced hands-on time, and greater workflow consistency, thereby advancing the efficiency and accuracy of genetic analysis. Empire Genomics LLC is a US-based healthcare technology company that specializes in the development of molecular diagnostic solutions, including FISH probes for clinical research and genetic testing.
Major companies operating in the fluorescent in situ hybridization probe market are Thermo Fisher Scientific Inc., Abbott Laboratories, Oxford Gene Technology IP Limited, Sigma-Aldrich Co. LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Leica Biosystems Nussloch GmbH, Biocare Medical LLC, Enzo Biochem Inc., LGC Biosearch Technologies, ZytoVision GmbH, Creative Biolabs Inc., Empire Genomics LLC, MetaSystems GmbH, Abnova Corporation, Mirus Bio LLC, Genemed Biotechnologies Inc., Molecular Instruments Inc., Cytocell Technologies Limited.
North America was the largest region in the fluorescent in situ hybridization probe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluorescent in situ hybridization probe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the fluorescent in situ hybridization probe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The fluorescent in situ hybridization probe market consists of revenues earned by entities by providing services such as cancer research, genetic disease detection, and drug development. The market value includes the value of related goods sold by the service provider or included within the service offering. The fluorescent in situ hybridization (FISH) probe market also includes sales of fluorescent dyes, hybridization buffers, detection reagents, control slides, and assay kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fluorescent In Situ Hybridization Probe Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses fluorescent in situ hybridization probe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for fluorescent in situ hybridization probe ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fluorescent in situ hybridization probe market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.